Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA
Clinical trial NCT04183712 · RECRUITING
Trial details
- NCT number
- NCT04183712
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2025-06-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.